The key to defeating MND lies in fostering strong collaboration between leading researchers around the world, and sharing new understanding of the disease as rapidly as possible. This was the […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
Results of the REFALS Study Merit Cudkowicz, MD, MSc Sean M. Healey & AMG Center for ALS at Mass General Hospital Tuesday, December 15, 2020 12:00 - 1:00 PM […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
Join our upcoming Virtual Event: Making an Impact on ALS Advocacy in Your Community, on Wednesday, January 13, 2021, at 1:30 p.m. (Pacific). Request an invitation and RSVP here.
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the […]
The National Organization for Rare Disorders (NORD), along with The ALS Association, Cystic Fibrosis Foundation and Muscular Dystrophy Association, is pleased to host a special webinar with leaders from the […]
Expanded Access to Investigational Drugs Friday, January 15, 2021 4:00 - 5:00 PM EST Join us for a webinar on Expanded Access Programs (EAPs). In EAPs people with ALS who are […]
Join us for a HEALEY ALS Platform Trial Webinar, "Pridopidine, Mechanism of Action and Science" with representatives from Prilenia, who will discuss Pridopidine, which is Regimen D in the HEALEY […]